A2E accumulation influences retinal microglial activation and complement regulation - Wikidata - awgldk - TriplyDB

A2E accumulation influences retinal microglial activation and complement regulation

A2E accumulation influences retinal microglial activation and complement regulation

http://www.wikidata.org/entity/Q36346763

about

The Photobiology of Lutein and Zeaxanthin in the Eye Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases Microglia communication: Parallels between aging and Alzheimer's disease Retinol Dehydrogenases Regulate Vitamin A Metabolism for Visual Function The Project MACULA Retinal Pigment Epithelium Grading System for Histology and Optical Coherence Tomography in Age-Related Macular Degeneration Synonymous variants in HTRA1 implicated in AMD susceptibility impair its capacity to regulate TGF-β signaling.A glimpse at the aging eye.Deletion of aryl hydrocarbon receptor AHR in mice leads to subretinal accumulation of microglia and RPE atrophy.γδ T cells as a major source of IL-17 production during age-dependent RPE degeneration.Morphological and physiological retinal degeneration induced by intravenous delivery of vitamin A dimers in rabbits.Synthesis and propagation of complement C3 by microglia/monocytes in the aging retina.7-Ketocholesterol increases retinal microglial migration, activation, and angiogenicity: a potential pathogenic mechanism underlying age-related macular degeneration Subducted and melanotic cells in advanced age-related macular degeneration are derived from retinal pigment epithelium Age-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?Di-retinoid-pyridinium-ethanolamine (A2E) Accumulation and the Maintenance of the Visual Cycle Are Independent of Atg7-mediated Autophagy in the Retinal Pigmented Epithelium Aging Changes in Retinal Microglia and their Relevance to Age-related Retinal Disease.670-nm light treatment reduces complement propagation following retinal degeneration.Defects in retinal pigment epithelial cell proteolysis and the pathology associated with age-related macular degeneration.Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation Gene expression changes in aging retinal microglia: relationship to microglial support functions and regulation of activation.Microglia during development and aging.Drusen regression is associated with local changes in fundus autofluorescence in intermediate age-related macular degeneration.Aging is not a disease: distinguishing age-related macular degeneration from aging.Associations Between Retinal Pigment Epithelium and Drusen Volume Changes During the Lifecycle of Large Drusenoid Pigment Epithelial Detachments.Multiple A2E treatments lead to melanization of rod outer segment-challenged ARPE-19 cells.Beta cyclodextrins bind, stabilize, and remove lipofuscin bisretinoids from retinal pigment epithelium.Inflammaging in skin and other tissues - the roles of complement system and macrophage.The role of glial cells and the complement system in retinal diseases and Alzheimer's disease: common neural degeneration mechanisms.Retinal pigment epithelium and microglia express the CD5 antigen-like protein, a novel autoantigen in age-related macular degeneration.Implementation studies of ranibizumab for neovascular age-related macular degeneration.VISUALIZING RETINAL PIGMENT EPITHELIUM PHENOTYPES IN THE TRANSITION TO GEOGRAPHIC ATROPHY IN AGE-RELATED MACULAR DEGENERATION.Tamoxifen Provides Structural and Functional Rescue in Murine Models of Photoreceptor Degeneration.Fasudil inhibits LPS-induced migration of retinal microglial cells via regulating p38-MAPK signaling pathway.Microglial phagocytosis and activation underlying photoreceptor degeneration is regulated by CX3CL1-CX3CR1 signaling in a mouse model of retinitis pigmentosa.Ischemic Retinopathies: Oxidative Stress and Inflammation.Blockade of microglial adenosine A2A receptor impacts inflammatory mechanisms, reduces ARPE-19 cell dysfunction and prevents photoreceptor loss in vitro.Retinal Histopathology in Eyes from a Patient with Stargardt disease caused by Compound Heterozygous ABCA4 Mutations.Microglia Activation and Immunomodulatory Therapies for Retinal Degenerations.

P2860

Q26769895-3D3600E2-86CC-4FDB-BB66-13C48BEE63CE Q27007111-1BB47E7A-835C-4501-959C-91A2717B17E3 Q28074099-6F5DD0DD-6E25-4151-943E-7C18760EF78C Q28077029-06D16F41-41CE-42BC-ACD5-2F856B6B01A6 Q28645952-67543A06-0B7A-4A68-A8CD-D37D1E904142 Q30378420-8B36FCE2-5C74-4729-9D81-824FB9AE0C7A Q33914344-E6DDFFED-1CC6-4770-9669-DFC6C71970EF Q34249884-CC182A58-5644-4B0B-8722-CB4A289FA17F Q34371913-49D1D98E-25D7-40FE-9A8E-DB618EE5307D Q35041343-E97AB717-6B3C-4CB0-BA53-C59AD0F3A4C5 Q35140051-6EBF7322-C689-4B02-99D7-B40D25E53CB7 Q35179686-31BEA9AA-B23F-411C-BA09-FDB80356B237 Q35677228-62F89018-B228-4632-9039-3793B569C3F2 Q35750545-FC7CF854-3D37-480E-B91C-BCFADDDF8CEB Q36323523-12048DB8-33D4-431D-B2DD-9506CD7AC544 Q36418255-04FB6062-FA8D-43D3-B44B-659F2E7C8324 Q36454668-FDFA9BC8-C694-47FA-A5CE-40B576DF9EFF Q36626060-6467BB68-7824-420C-BC0D-C8DC57F860E7 Q36678453-73380A82-2BDA-4D3D-8F2C-EFFB8221056D Q36997157-38D3A3C3-1E9B-4813-BE34-189386F4A27B Q37080038-84A571E7-E002-440E-BEC8-292E67F4D2E2 Q37107078-801B2759-6D15-4503-8EBA-754DFB4B00C1 Q37315838-15E43604-DA23-4E67-9E4A-C6BA116A02E9 Q37354226-D3D27A7E-06CD-4828-8A0B-256322F5FCEE Q37639380-91832BE8-89F1-46E2-A978-91A7242B419A Q37701967-6D0656C6-23AA-498E-ACF7-E5660908EE24 Q38213952-7E5DF316-41F0-42F9-813A-94CC8F56F624 Q38245648-11B5759E-1F77-439F-B22E-1AC4F080AF47 Q38725575-56416BDA-E243-4F46-BB71-00F7CC545FCF Q39316202-BE6ADBD9-9A5B-4FD2-94AD-6BD1B9AB8412 Q40411841-562CDE2C-81CA-4EFA-8E56-A0026AB6FC86 Q41700375-F21424E0-053A-48B7-838D-F959E71CB118 Q42059286-01B960A3-0150-4EAC-A784-BB81C3A8F98E Q42174317-D5AD433F-D2E2-40F5-A09B-4B4EDA6549D2 Q48095108-85532DD8-9846-4C19-BBE0-AD5FE2A6B154 Q48112715-BE2CF21D-B16D-4909-A575-2C15A3AC84C3 Q51110368-40AC6929-29D4-4840-A15D-167C2203D089 Q55436247-2DEBCA7F-90F1-4741-B3D7-637680821F4B

P2860

A2E accumulation influences retinal microglial activation and complement regulation

http://www.wikidata.org/entity/Q36346763

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

A2E accumulation influences retinal microglial activation and complement regulation

@ast

A2E accumulation influences retinal microglial activation and complement regulation

@en

type

label

A2E accumulation influences retinal microglial activation and complement regulation

@ast

A2E accumulation influences retinal microglial activation and complement regulation

@en

prefLabel

A2E accumulation influences retinal microglial activation and complement regulation

@ast

A2E accumulation influences retinal microglial activation and complement regulation

@en

P1433

Q36346763-64F33B23-DB4E-4720-A218-9C9EFFBBDCF4

P1476

Q36346763-48A9D065-567A-43B4-A02A-43574800DD29

P2093

Q36346763-366A9AA8-CD06-4A14-AA6B-4221462F3E61

Q36346763-C84B2B1A-9018-4EDD-A463-B040C1836130

P2860

Q36346763-0048CA73-834C-4D4C-B901-A0BB4552BA9E

Q36346763-0418671F-8381-40ED-8555-BD7DF6D7FDAA

Q36346763-148459E6-9A04-4753-9A9D-F0D3ADC7092B

Q36346763-1687A98E-6770-417D-AABE-631451F419F4

Q36346763-2273FA85-0D2D-4F4F-A634-CE4A53C91286

Q36346763-2804E363-5FAA-4C10-90D7-CD494705B3BB

Q36346763-2A3FEFC6-AD4B-4044-98A9-03830196E80E

Q36346763-2F760812-77EA-41E4-B10D-40E1E65C1123

Q36346763-3456B6CF-60D8-4E3B-9688-21D3AC49B2EF

Q36346763-3711A260-72D5-4E3A-895F-7F24FF8F3061

P304

Q36346763-F58D0920-7B34-4275-B423-C9E93F9707B8

P31

Q36346763-78C5B60B-A9BC-41C2-B90E-86125D52DDB8

P356

Q36346763-CA169837-B1F0-4FFF-B7EF-B8CC9A3F056C

P433

Q36346763-A8A0B077-B85C-45EA-8C11-DC53C3CC8014

P478

Q36346763-1A02C70D-77E3-4704-B226-212627F02C4A

P50

Q36346763-0D5749B6-1DCE-469F-8563-4A7BA873B438

Q36346763-88604B2C-5C68-4049-BF8F-47A38CA3CA82

Q36346763-99F1BB4B-5229-42B7-B388-5F1FE0669E5B

P577

Q36346763-F753576C-F787-467F-B002-0D3329AF7E3A

P698

Q36346763-A6031633-3C70-4908-95DF-5FDAC004D1AE

P921

Q36346763-8ABA0109-E294-41C2-8399-CB4545325928

Q36346763-B5937DC5-9291-4F3F-8016-DB435143681C

P932

Q36346763-987924A2-DCA8-4586-9246-252902AA349F

P356

J.NEUROBIOLAGING.2012.06.010

P1433

Neurobiology of Aging

P1476

A2E accumulation influences retinal microglial activation and complement regulation

@en

P2093

Robert N Fariss

http://www.w3.org/2001/XMLSchema#string

Steven Coon

http://www.w3.org/2001/XMLSchema#string

P2860

The yin and yang of microglia

Systemic complement activation in age-related macular degeneration

Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium

The chemokine system in diverse forms of macrophage activation and polarization

Direct multiplexed measurement of gene expression with color-coded probe pairs

Prevalence of age-related macular degeneration in the United States

Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion

Age-related alterations in the dynamic behavior of microglia.

Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD.

Microglial involvement in neuroplastic changes following focal brain ischemia in rats.

P304

943-960

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEUROBIOLAGING.2012.06.010

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22819137

http://www.w3.org/2001/XMLSchema#string

P921

N-retinylidene-N-retinylethanolamine

P932

3480997

http://www.w3.org/2001/XMLSchema#string